Keane, A.; Tippett, A.; Taylor, E.G.; Reese, O.; Salazar, L.; De Castro, K.; Choi, C.; Ciric, C.; Taylor, M.; Mitchell, A.;
et al. Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study. Vaccines 2024, 12, 657.
https://doi.org/10.3390/vaccines12060657
AMA Style
Keane A, Tippett A, Taylor EG, Reese O, Salazar L, De Castro K, Choi C, Ciric C, Taylor M, Mitchell A,
et al. Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study. Vaccines. 2024; 12(6):657.
https://doi.org/10.3390/vaccines12060657
Chicago/Turabian Style
Keane, Amy, Ashley Tippett, Elizabeth Grace Taylor, Olivia Reese, Luis Salazar, Khalel De Castro, Chris Choi, Caroline Ciric, Meg Taylor, Anna Mitchell,
and et al. 2024. "Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study" Vaccines 12, no. 6: 657.
https://doi.org/10.3390/vaccines12060657
APA Style
Keane, A., Tippett, A., Taylor, E. G., Reese, O., Salazar, L., De Castro, K., Choi, C., Ciric, C., Taylor, M., Mitchell, A., Gibson, T., Puzniak, L., Hubler, R., Valluri, S. R., Wiemken, T. L., Lopman, B. A., Kamidani, S., Anderson, L. J., McLaughlin, J. M.,
... Anderson, E. J.
(2024). Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study. Vaccines, 12(6), 657.
https://doi.org/10.3390/vaccines12060657